Did You Know?

Editor’s Picks

Latest News

TriSalus Life Sciences Announces Launch of PREDICTT Clinical Trial Evaluating Pressure-Enabled Drug Delivery in Liver Tumors

WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of...

Mobile-health Network Solutions Enters into Non-Binding US$119 Million Strategic Framework with Hector Capital to Acquire BIMA and M&M Helix, Accelerating AI-powered Healthcare Expansion across Asia and Africa

error: Content is protected !!